PeptSense
Create account

Peptide research

CJC-1295 — compounding legality overview

CJC-1295 (with or without DAC) is a growth-hormone-releasing hormone analog commonly stacked in peptide therapy. Alias handling matters for lookup — DAC vs no-DAC forms may be treated differently in curation.

Growth hormone releasing hormone analog

Common names: CJC-1295 DAC, CJC-1295 without DAC, CJC-1295 no DAC

PeptSense tracks CJC-1295 across federal 503A Bulks List chain steps, PCAC advisory context, and state board positions. Status is never inferred from forums or marketing sites — only published citations with effective dates.

Federal 503A snapshot (illustrative)

Latest published federal event for 503A compounding pharmacies. Sign in for your licensed states and facility type.

Unclear
Summary
Honest curation baseline (2026-08-01): no confident Bulks List / USP / approved-component chain step assigned for CJC-1295 in this pass. Unclear until a human verifies a substance-specific citation. Not a legal determination.
Citation
FDA — 503A bulk drug substances page
Effective
Aug. 1, 2026

Not a legal determination. Replace placeholder citations during curation.

Run a full lookup

Get federal + state lanes, chain steps, printable answer cards, and compliance documents for the states you license in.

Create account View pricing

Related research topics

  • CJC-1295 compounding
  • CJC-1295 legality
  • CJC-1295 pharmacy

← All peptides · Resources hub